Ornithine Transcarbamylase Deficiency News and Research

RSS
Medunik announces availability of PHEBURANE drug in Canada for chronic management of UCD

Medunik announces availability of PHEBURANE drug in Canada for chronic management of UCD

Arcturus to exhibit new mRNA therapeutics pipeline at two healthcare conferences

Arcturus to exhibit new mRNA therapeutics pipeline at two healthcare conferences

Urea cycle disorder patient successfully treated by Promethera(R) HepaStem in Phase I/II trial in France

Urea cycle disorder patient successfully treated by Promethera(R) HepaStem in Phase I/II trial in France

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.